Lamyaa Al-Dalawi earned a BSc (Hons) in Veterinary Medicine and Science and later completed a master’s degree in Internal and Preventive Medicine at the Veterinary College. In 2014, she was awarded a scholarship to pursue a PhD in Veterinary Medicine and Science at the University of Nottingham, where her research focused on exploring the antiviral potential of exogenous phospholipids against influenza A viruses in vitro. In 2020, she joined the SVMS as a postdoctoral research fellow, with her work centered on antiviral therapies targeting RNA viruses, including influenza virus, SARS-CoV-2, and Zika virus. Currently, she contributes to the Flu-Map project, which investigates the animal health risks associated with emerging H5 highly pathogenic avian influenza viruses.